Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome
Noonan
1 other identifier
observational
100
1 country
1
Brief Summary
The present study will establish a collection of biological samples from Noonan patients to be used for research purposes only, with due respect for confidentiality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2022
CompletedFirst Posted
Study publicly available on registry
January 21, 2022
CompletedStudy Start
First participant enrolled
January 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 26, 2032
March 19, 2026
March 1, 2026
5 years
January 7, 2022
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Constitution of a biological collection from patients with Noonan or related syndromes.
extra sample of blood and urine will be collected
inclusion
Study Arms (1)
patients with Noonan syndrome
extra sample of blood and urine will be collected and stored for research utilisation
Interventions
extra sample of blood and urine will be collected
Eligibility Criteria
Patients with Noonan syndrome
You may qualify if:
- Children aged at least 3 years old or adult with Noonan syndrome
- Patients affiliated to or beneficiaries of a social security scheme
- Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities
- Patients or legal representative who have given their consent to participate in the study (expression of no objection)
You may not qualify if:
- Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice)
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Purpan University Hospital
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas EDOUARD, MD PhD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2022
First Posted
January 21, 2022
Study Start
January 26, 2022
Primary Completion (Estimated)
January 26, 2027
Study Completion (Estimated)
January 26, 2032
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share